USA Postoperative Nausea and Vomiting (PONV) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Postoperative Nausea and Vomiting (PONV) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Postoperative Nausea and Vomiting (PONV) market. Detailed analysis of key players, along with key growth strategies adopted by Postoperative Nausea and Vomiting (PONV) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novartis

    • Ani Pharmaceuticals

    • Sanofi

    • Camurus

    • Merck

    • F Hoffmann-La Roche

    • Helsinn Holding

    • GlaxoSmithKline

    • Acacia Pharma

    • Eisai

    By Type:

    • Serotonin Antagonists

    • Steroids

    • Dopamine Antagonists

    • NK-1 Receptor Antagonists

    • Others

    • Non-pharmacologic Treatment

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies and Drug Stores

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Postoperative Nausea and Vomiting (PONV) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Serotonin Antagonists from 2016 to 2027

      • 1.3.2 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Steroids from 2016 to 2027

      • 1.3.3 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Dopamine Antagonists from 2016 to 2027

      • 1.3.4 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of NK-1 Receptor Antagonists from 2016 to 2027

      • 1.3.5 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Others from 2016 to 2027

      • 1.3.6 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Non-pharmacologic Treatment from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

      • 1.4.2 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

      • 1.4.3 USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Retail Pharmacies and Drug Stores from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Postoperative Nausea and Vomiting (PONV) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Postoperative Nausea and Vomiting (PONV) by Major Types

      • 3.4.1 Market Size and Growth Rate of Serotonin Antagonists

      • 3.4.2 Market Size and Growth Rate of Steroids

      • 3.4.3 Market Size and Growth Rate of Dopamine Antagonists

      • 3.4.4 Market Size and Growth Rate of NK-1 Receptor Antagonists

      • 3.4.5 Market Size and Growth Rate of Others

      • 3.4.6 Market Size and Growth Rate of Non-pharmacologic Treatment

    4 Segmentation of Postoperative Nausea and Vomiting (PONV) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Postoperative Nausea and Vomiting (PONV) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Postoperative Nausea and Vomiting (PONV) in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Postoperative Nausea and Vomiting (PONV) in Online Pharmacies

      • 4.4.3 Market Size and Growth Rate of Postoperative Nausea and Vomiting (PONV) in Retail Pharmacies and Drug Stores

    5 Market Analysis by Regions

    • 5.1 USA Postoperative Nausea and Vomiting (PONV) Production Analysis by Regions

    • 5.2 USA Postoperative Nausea and Vomiting (PONV) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis

    • 6.1 West USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major Types

    • 6.2 West USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major End-Users

    7 South USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis

    • 7.1 South USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major Types

    • 7.2 South USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major End-Users

    8 Middle West USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis

    • 8.1 Middle West USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major Types

    • 8.2 Middle West USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major End-Users

    9 Northeast USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis

    • 9.1 Northeast USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major Types

    • 9.2 Northeast USA Postoperative Nausea and Vomiting (PONV) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novartis

        • 10.1.1 Novartis Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Ani Pharmaceuticals

        • 10.2.1 Ani Pharmaceuticals Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sanofi

        • 10.3.1 Sanofi Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Camurus

        • 10.4.1 Camurus Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Merck

        • 10.5.1 Merck Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 F Hoffmann-La Roche

        • 10.6.1 F Hoffmann-La Roche Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Helsinn Holding

        • 10.7.1 Helsinn Holding Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 GlaxoSmithKline

        • 10.8.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Acacia Pharma

        • 10.9.1 Acacia Pharma Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Eisai

        • 10.10.1 Eisai Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Serotonin Antagonists from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Steroids from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Dopamine Antagonists from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of NK-1 Receptor Antagonists from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Non-pharmacologic Treatment from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • Figure USA Postoperative Nausea and Vomiting (PONV) Market Size and Growth Rate of Retail Pharmacies and Drug Stores from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Postoperative Nausea and Vomiting (PONV) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Postoperative Nausea and Vomiting (PONV)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Postoperative Nausea and Vomiting (PONV) by Different Types from 2016 to 2027

    • Table Consumption Share of Postoperative Nausea and Vomiting (PONV) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Serotonin Antagonists

    • Figure Market Size and Growth Rate of Steroids

    • Figure Market Size and Growth Rate of Dopamine Antagonists

    • Figure Market Size and Growth Rate of NK-1 Receptor Antagonists

    • Figure Market Size and Growth Rate of Others

    • Figure Market Size and Growth Rate of Non-pharmacologic Treatment

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Postoperative Nausea and Vomiting (PONV) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Postoperative Nausea and Vomiting (PONV) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies and Drug Stores

    • Table USA Postoperative Nausea and Vomiting (PONV) Production by Regions

    • Table USA Postoperative Nausea and Vomiting (PONV) Production Share by Regions

    • Figure USA Postoperative Nausea and Vomiting (PONV) Production Share by Regions in 2016

    • Figure USA Postoperative Nausea and Vomiting (PONV) Production Share by Regions in 2021

    • Figure USA Postoperative Nausea and Vomiting (PONV) Production Share by Regions in 2027

    • Table USA Postoperative Nausea and Vomiting (PONV) Consumption by Regions

    • Table USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Regions

    • Figure USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Regions in 2016

    • Figure USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Regions in 2021

    • Figure USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Regions in 2027

    • Table West USA Postoperative Nausea and Vomiting (PONV) Consumption by Types from 2016 to 2027

    • Table West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types from 2016 to 2027

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2016

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2021

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2027

    • Table West USA Postoperative Nausea and Vomiting (PONV) Consumption by End-Users from 2016 to 2027

    • Table West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2016

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2021

    • Figure West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2027

    • Table South USA Postoperative Nausea and Vomiting (PONV) Consumption by Types from 2016 to 2027

    • Table South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types from 2016 to 2027

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2016

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2021

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2027

    • Table South USA Postoperative Nausea and Vomiting (PONV) Consumption by End-Users from 2016 to 2027

    • Table South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2016

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2021

    • Figure South USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2027

    • Table Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption by Types from 2016 to 2027

    • Table Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2016

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2021

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2027

    • Table Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2016

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2021

    • Figure Middle West USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2027

    • Table Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption by Types from 2016 to 2027

    • Table Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2016

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2021

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by Types in 2027

    • Table Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2016

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2021

    • Figure Northeast USA Postoperative Nausea and Vomiting (PONV) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Ani Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ani Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ani Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ani Pharmaceuticals

    • Table Product and Service Introduction of Ani Pharmaceuticals

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Camurus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Camurus

    • Figure Sales and Growth Rate Analysis of Camurus

    • Figure Revenue and Market Share Analysis of Camurus

    • Table Product and Service Introduction of Camurus

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of F Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Product and Service Introduction of F Hoffmann-La Roche

    • Table Company Profile and Development Status of Helsinn Holding

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Holding

    • Figure Sales and Growth Rate Analysis of Helsinn Holding

    • Figure Revenue and Market Share Analysis of Helsinn Holding

    • Table Product and Service Introduction of Helsinn Holding

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Acacia Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acacia Pharma

    • Figure Sales and Growth Rate Analysis of Acacia Pharma

    • Figure Revenue and Market Share Analysis of Acacia Pharma

    • Table Product and Service Introduction of Acacia Pharma

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.